”Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol”. Proceedings of the National Academy of Sciences of the United States of America 118 (33): sid. e2102191118. August 2021. doi:10.1073/pnas.2102191118. PMID 34385305.
”Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide”. Nature Reviews. Molecular Cell Biology 8 (2): sid. 101–12. February 2007. doi:10.1038/nrm2101. PMID 17245412.
”Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies”. Journal of Alzheimer's Disease 18 (2): sid. 401–12. 2009. doi:10.3233/JAD-2009-1154. PMID 19584429.
”Beta-amyloid exhibits antagonistic effects on alpha 7 nicotinic acetylcholine receptors in orchestrated manner”. Journal of Medical Hypotheses and Ideas 8 (2): sid. 48–52. 2014. doi:10.1016/j.jmhi.2014.01.001.
”BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time”. Neurobiology of Disease 14 (1): sid. 81–8. doi:10.1016/S0969-9961(03)00104-9. PMID 13678669.
”Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential”. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1697 (1–2): sid. 89–101. doi:10.1016/j.bbapap.2003.11.016. PMID 15023353.
”A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage”. The Journal of Neuroscience 22 (12): sid. 4833–41. doi:10.1523/JNEUROSCI.22-12-04833.2002. PMID 12077180.
”Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems”. Biochemistry 48 (20): sid. 4354–70. doi:10.1021/bi802361k. PMID 19320465.
”Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity”. FASEB Journal 16 (12): sid. 1677–9. doi:10.1096/fj.02-0285fje. PMID 12206998.
”Amyloid beta-protein stimulates trafficking of cholesterol and caveolin-1 from the plasma membrane to the Golgi complex in mouse primary astrocytes”. Neuroscience 162 (2): sid. 328–38. doi:10.1016/j.neuroscience.2009.04.049. PMID 19401218.
”The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif”. Gene 488 (1–2): sid. 1–12. doi:10.1016/j.gene.2011.06.004. PMID 21699964.
”Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis”. Gene 488 (1–2): sid. 13–22. doi:10.1016/j.gene.2011.06.017. PMID 21708232.
”Antimicrobial peptides in the brain: neuropeptides and amyloid”. Frontiers in Bioscience 4 (4): sid. 1375–80. doi:10.2741/S339. PMID 22652879.
”Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis”. Translational Neurodegeneration 7: sid. 34. doi:10.1186/s40035-018-0139-3. PMID 30603085.
”A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β”. Science Translational Medicine 4 (147): sid. 147ra111. August 2012. doi:10.1126/scitranslmed.3003748. PMID 22896675.
”Clearance systems in the brain-implications for Alzheimer disease”. Nature Reviews. Neurology 11 (8): sid. 457–70. August 2015. doi:10.1038/nrneurol.2015.119. PMID 26195256.
”The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease”. The Journal of Biological Chemistry 271 (50): sid. 32185–91. doi:10.1074/jbc.271.50.32185. PMID 8943274.
”The toxicity of amyloid β oligomers”. International Journal of Molecular Sciences 13 (6): sid. 7303–27. 2012. doi:10.3390/ijms13067303. PMID 22837695.
”Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis”. Science 300 (5618): sid. 486–9. April 2003. doi:10.1126/science.1079469. PMID 12702875.
”Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer”. Neurotoxicity Research 31 (2): sid. 283–288. February 2017. doi:10.1007/s12640-016-9682-9. PMID 27913965.
”Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer”. BMC Cancer 14: sid. 928. December 2014. doi:10.1186/1471-2407-14-928. PMID 25491510.
”Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis”. European Journal of Nuclear Medicine and Molecular Imaging 43 (2): sid. 362–373. doi:10.1007/s00259-015-3208-1. PMID 26440450.
”Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184”. Journal of Nuclear Medicine 55 (6): sid. 932–8. doi:10.2967/jnumed.113.133793. PMID 24732152.
Tissue processing prior to analysis of Alzheimer's disease associated proteins and metabolites, including Aβ. "849". sid. 493–506. doi:10.1007/978-1-61779-551-0_33
”In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis”. The Journal of Biological Chemistry 278 (13): sid. 11612–22. March 2003. doi:10.1074/jbc.M210207200. PMID 12499373.
”Microspectroscopy (μFTIR) reveals co-localization of lipid oxidation and amyloid plaques in human Alzheimer disease brains”. Analytical Chemistry 86 (24): sid. 12047–54. December 2014. doi:10.1021/ac502667b. PMID 25415602.
”Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background”. Experimental Brain Research 179 (4): sid. 621–30. doi:10.1007/s00221-006-0819-6. PMID 17171334.
”Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species”. The FEBS Journal 274 (24): sid. 6290–304. doi:10.1111/j.1742-4658.2007.06144.x. PMID 18005258.
”Insight into early events in the aggregation of the prion protein on lipid membranes”. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (10): sid. 2245–51. doi:10.1016/j.bbamem.2009.08.005. PMID 19703409.
”Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol”. Proceedings of the National Academy of Sciences of the United States of America 118 (33): sid. e2102191118. August 2021. doi:10.1073/pnas.2102191118. PMID 34385305.
”Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide”. Nature Reviews. Molecular Cell Biology 8 (2): sid. 101–12. February 2007. doi:10.1038/nrm2101. PMID 17245412.
”Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies”. Journal of Alzheimer's Disease 18 (2): sid. 401–12. 2009. doi:10.3233/JAD-2009-1154. PMID 19584429.
”BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time”. Neurobiology of Disease 14 (1): sid. 81–8. doi:10.1016/S0969-9961(03)00104-9. PMID 13678669.
”Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential”. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1697 (1–2): sid. 89–101. doi:10.1016/j.bbapap.2003.11.016. PMID 15023353.
”A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage”. The Journal of Neuroscience 22 (12): sid. 4833–41. doi:10.1523/JNEUROSCI.22-12-04833.2002. PMID 12077180.
”Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems”. Biochemistry 48 (20): sid. 4354–70. doi:10.1021/bi802361k. PMID 19320465.
”Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity”. FASEB Journal 16 (12): sid. 1677–9. doi:10.1096/fj.02-0285fje. PMID 12206998.
”Amyloid beta-protein stimulates trafficking of cholesterol and caveolin-1 from the plasma membrane to the Golgi complex in mouse primary astrocytes”. Neuroscience 162 (2): sid. 328–38. doi:10.1016/j.neuroscience.2009.04.049. PMID 19401218.
”The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif”. Gene 488 (1–2): sid. 1–12. doi:10.1016/j.gene.2011.06.004. PMID 21699964.
”Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis”. Gene 488 (1–2): sid. 13–22. doi:10.1016/j.gene.2011.06.017. PMID 21708232.
”Antimicrobial peptides in the brain: neuropeptides and amyloid”. Frontiers in Bioscience 4 (4): sid. 1375–80. doi:10.2741/S339. PMID 22652879.
”Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis”. Translational Neurodegeneration 7: sid. 34. doi:10.1186/s40035-018-0139-3. PMID 30603085.
”A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β”. Science Translational Medicine 4 (147): sid. 147ra111. August 2012. doi:10.1126/scitranslmed.3003748. PMID 22896675.
”Clearance systems in the brain-implications for Alzheimer disease”. Nature Reviews. Neurology 11 (8): sid. 457–70. August 2015. doi:10.1038/nrneurol.2015.119. PMID 26195256.
”The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease”. The Journal of Biological Chemistry 271 (50): sid. 32185–91. doi:10.1074/jbc.271.50.32185. PMID 8943274.
”The toxicity of amyloid β oligomers”. International Journal of Molecular Sciences 13 (6): sid. 7303–27. 2012. doi:10.3390/ijms13067303. PMID 22837695.
”Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis”. Science 300 (5618): sid. 486–9. April 2003. doi:10.1126/science.1079469. PMID 12702875.
”Plasma Amyloid-Beta Levels in Patients with Different Types of Cancer”. Neurotoxicity Research 31 (2): sid. 283–288. February 2017. doi:10.1007/s12640-016-9682-9. PMID 27913965.
”Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer”. BMC Cancer 14: sid. 928. December 2014. doi:10.1186/1471-2407-14-928. PMID 25491510.
”Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis”. European Journal of Nuclear Medicine and Molecular Imaging 43 (2): sid. 362–373. doi:10.1007/s00259-015-3208-1. PMID 26440450.
”Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184”. Journal of Nuclear Medicine 55 (6): sid. 932–8. doi:10.2967/jnumed.113.133793. PMID 24732152.
”In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis”. The Journal of Biological Chemistry 278 (13): sid. 11612–22. March 2003. doi:10.1074/jbc.M210207200. PMID 12499373.
”Microspectroscopy (μFTIR) reveals co-localization of lipid oxidation and amyloid plaques in human Alzheimer disease brains”. Analytical Chemistry 86 (24): sid. 12047–54. December 2014. doi:10.1021/ac502667b. PMID 25415602.
”Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background”. Experimental Brain Research 179 (4): sid. 621–30. doi:10.1007/s00221-006-0819-6. PMID 17171334.
”Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species”. The FEBS Journal 274 (24): sid. 6290–304. doi:10.1111/j.1742-4658.2007.06144.x. PMID 18005258.
”Insight into early events in the aggregation of the prion protein on lipid membranes”. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (10): sid. 2245–51. doi:10.1016/j.bbamem.2009.08.005. PMID 19703409.
